Trade DRMA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Dermata Therapeutics, Inc. (DRMA) is trading at US$1.15, down 0.86% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$7.04M. Over the past 52 weeks, DRMA has traded between US$0.95 and US$5.87. On Syfe you can trade DRMA with $0 commission and add it to your watchlist.
| Previous close | US$1.16 |
|---|---|
| Market cap | US$7.04M |
| 52-week range | US$0.95 – US$5.87 |
| Volume | 19.58K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Dermata Therapeutics, Inc.
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.
Year: 2021
Dermata Therapeutics, Inc. (DRMA) stock is trading at US$1.15, -0.86% from the previous close of US$1.16.
The market cap for Dermata Therapeutics, Inc. (DRMA) stock is approximately US$7.04M.
The 52-week high for Dermata Therapeutics, Inc. (DRMA) stock is US$5.87.
The 52-week low for Dermata Therapeutics, Inc. (DRMA) stock is US$0.95.
Dermata Therapeutics, Inc. (DRMA) does not currently pay a dividend.
Stay on top of DRMA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
